These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 22206663)
1. Targeting receptor for advanced glycation end products (RAGE) expression induces apoptosis and inhibits prostate tumor growth. Elangovan I; Thirugnanam S; Chen A; Zheng G; Bosland MC; Kajdacsy-Balla A; Gnanasekar M Biochem Biophys Res Commun; 2012 Jan; 417(4):1133-8. PubMed ID: 22206663 [TBL] [Abstract][Full Text] [Related]
2. Quercetin protects necrotic insult and promotes apoptosis by attenuating the expression of RAGE and its ligand HMGB1 in human breast adenocarcinoma cells. Dhumale SS; Waghela BN; Pathak C IUBMB Life; 2015 May; 67(5):361-73. PubMed ID: 25983116 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo. Zhang J; Zhu JS; Zhou Z; Chen WX; Chen NW Oncol Rep; 2012 May; 27(5):1511-9. PubMed ID: 22246223 [TBL] [Abstract][Full Text] [Related]
4. A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model. Saleem M; Kweon MH; Yun JM; Adhami VM; Khan N; Syed DN; Mukhtar H Cancer Res; 2005 Dec; 65(23):11203-13. PubMed ID: 16322271 [TBL] [Abstract][Full Text] [Related]
5. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development. Ishiguro H; Nakaigawa N; Miyoshi Y; Fujinami K; Kubota Y; Uemura H Prostate; 2005 Jun; 64(1):92-100. PubMed ID: 15666359 [TBL] [Abstract][Full Text] [Related]
6. Cell-selective gene silencing in prostate cancer LNCap cells using prostate-specific membrane antigen promoter and enhancer in vitro and in vivo. Liu R; Sun J; Zhang Z; Xu Y Cell Biol Int; 2012 Oct; 36(10):863-72. PubMed ID: 22612256 [TBL] [Abstract][Full Text] [Related]
7. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis. Rocchi P; Beraldi E; Ettinger S; Fazli L; Vessella RL; Nelson C; Gleave M Cancer Res; 2005 Dec; 65(23):11083-93. PubMed ID: 16322258 [TBL] [Abstract][Full Text] [Related]
8. Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways. Cheng P; Dai W; Wang F; Lu J; Shen M; Chen K; Li J; Zhang Y; Wang C; Yang J; Zhu R; Zhang H; Zheng Y; Guo CY; Xu L Biochem Biophys Res Commun; 2014 Jan; 443(4):1162-8. PubMed ID: 24361892 [TBL] [Abstract][Full Text] [Related]
9. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076 [TBL] [Abstract][Full Text] [Related]
10. HMGB1, S100 proteins and other RAGE ligands in cancer - markers, mediators and putative therapeutic targets. Tesarova P; Kalousova M; Zima T; Tesar V Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):1-10. PubMed ID: 26847418 [TBL] [Abstract][Full Text] [Related]
11. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase. Igawa T; Lin FF; Rao P; Lin MF Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404 [TBL] [Abstract][Full Text] [Related]
12. HMGB1 modulates Lewis cell autophagy and promotes cell survival via RAGE-HMGB1-Erk1/2 positive feedback during nutrient depletion. Su Z; Wang T; Zhu H; Zhang P; Han R; Liu Y; Ni P; Shen H; Xu W; Xu H Immunobiology; 2015 May; 220(5):539-44. PubMed ID: 25578401 [TBL] [Abstract][Full Text] [Related]
13. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11. Ray S; Almasan A Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654 [TBL] [Abstract][Full Text] [Related]
14. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts. Liu CM; Lo YC; Tai MH; Wu BN; Wu WJ; Chou YH; Chai CY; Huang CH; Chen IJ Prostate; 2009 May; 69(6):610-23. PubMed ID: 19143029 [TBL] [Abstract][Full Text] [Related]
15. Activation of the receptor for advanced glycation end products induces nuclear inhibitor of protein phosphatase-1 suppression. Liebisch M; Bondeva T; Franke S; Daniel C; Amann K; Wolf G Kidney Int; 2014 Jul; 86(1):103-17. PubMed ID: 24476693 [TBL] [Abstract][Full Text] [Related]
16. Tumor-specific RNA interference targeting Pokemon suppresses tumor growth and induces apoptosis in prostate cancer. Li Y; Xu S; Wang X; Shi H; Sun Z; Yang Z Urology; 2013 Feb; 81(2):467.e1-7. PubMed ID: 23374847 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor. Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer. You Z; Shi XB; DuRaine G; Haudenschild D; Tepper CG; Lo SH; Gandour-Edwards R; de Vere White RW; Reddi AH Cancer Res; 2006 Jan; 66(1):175-83. PubMed ID: 16397230 [TBL] [Abstract][Full Text] [Related]
19. Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitro. Rocchi P; Jugpal P; So A; Sinneman S; Ettinger S; Fazli L; Nelson C; Gleave M BJU Int; 2006 Nov; 98(5):1082-9. PubMed ID: 16879439 [TBL] [Abstract][Full Text] [Related]
20. HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi. Ahrens I; Chen YC; Topcic D; Bode M; Haenel D; Hagemeyer CE; Seeba H; Duerschmied D; Bassler N; Jandeleit-Dahm KA; Sweet MJ; Agrotis A; Bobik A; Peter K Thromb Haemost; 2015 Nov; 114(5):994-1003. PubMed ID: 26202300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]